Navigation Links
'Best CRO' Award Recognizes Accelovance's Support of Vaccine Development
Date:4/30/2009

ROCKVILLE, Md., April 30 /PRNewswire/ -- Accelovance, a privately held vaccine-focused clinical research company, announced today it received the Vaccine Industry Excellence (ViE) award as "Best Contract Research Organization" (CRO) at the 2009 World Vaccine Congress, held recently in Chantilly, VA.

The ViE awards were established to generate public recognition of the efforts, accomplishments, and positive contributions of organizations and individuals in the global vaccine industry. The "Best CRO" award is designed to highlight the importance of contract research services within the vaccine industry. It identifies Accelovance as best-in-class for services that advance vaccine development.

"There is obviously tremendous pride with this award. It reflects our commitment to excellence and focus on the niche market of vaccines," commented Steve Trevisan, President and CEO of Accelovance. "This award recognizes how we have served clients, both large and small, across all stages of clinical development by providing solutions to their needs or challenges. We will continue to focus on our clients and our mission of bringing innovation, operational efficiencies and high quality performance at multiple levels through our offering of CRO, Clinical Sites, Patient Recruitment and Clinical Call Center services."

A panel of international judges reviews nominations to determine each year's recipients of the ViE awards. In 2008, Accelovance was a finalist in the same category of "Best CRO."

Headquartered in Rockville, Maryland, Accelovance is a privately held company that has developed a unique operational approach for delivering quality, on time, and cost-effective clinical studies. Accelovance offers seven (7) wholly-owned, research-dedicated clinical sites to Sponsors and CROs that bring greater control, predictability, and quality assurance to vaccine programs. Additionally, the Company tailors it
'/>"/>

SOURCE Accelovance
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
2. How Best to Treat Preschoolers With ADHD? The Harvard Mental Health Letter Discusses the Options
3. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
4. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
5. Abaxis to Present at the CL King Best Ideas Conference 2007
6. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
7. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
8. Methadone and systematic follow-up: the best solution for managing chronic pain
9. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
10. GPS-like technology helps pinpoint best methods for moving injured players
11. Aerobic, Weight Training Combo Best Against Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... V/NO (Virtually No Alcohol) Wines have a ... opening/closing and for reuse. Consumers simply twist the cup, turn ... Yorkers, professionals, and basically anyone can now enjoy a ... back socially or pair with meals at work, home, or ... wine and that means Napa Wine grapes undergo the ...
(Date:3/30/2015)... 30, 2015 South Coast Surety is pleased ... Bond Representative. Richard has been known to the management of ... Richard attended the University of Georgia, majoring in Banking and ... the sales and sales management of business equipment for a ... Most recently, Richard was a senior officer with a National ...
(Date:3/30/2015)... 30, 2015 Considered to be the ... in the global business community, this next generation of ... ante by managing big data and frameworks with virtually ... already powerful analytic and logic features are a technological ... of Lazarus Alliance said “The IT Audit Machine is ...
(Date:3/30/2015)... GREEN, Ohio (PRWEB) March 30, 2015 ... a globally recognized designer and manufacturer of ... and vinyl upholstery options. The new upholsteries ... laboratory, education and custom seating, providing disinfectable, ... are manufactured by renowned textile purveyor CF ...
(Date:3/29/2015)... 2015 Pro Ace Care Heating & ... now provide qualified HVAC technicians that will visit the ... and related systems throughout Vancouver, North Vancouver, Burnaby, Richmond, ... conditioners, heat pumps require regular maintenance from a professional. ... BC Hydro strongly suggest you have it serviced annually ...
Breaking Medicine News(10 mins):Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Richard Ford Joins South Coast Surety Contract Surety Team 2Health News:Building on Success: Next Generation of Cyber Crime Prevention Unveiled! 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Pro Ace Care Now Provides Qualified HVAC Technicians for Heat Pump Maintenance 2
... , , Mr. Randall Terry and ... city tour, where they held press conferences, performed street theatre, and ... HR 3200. More Details and links at www.OverturnRoe.com , , ... by Randall Terry, founder of Operation Rescue. , , ...
... WASHINGTON, Aug. 26 Loretta King, Acting Assistant Attorney General ... a federal grand jury in Denver has charged Donald Hertz ... the Freedom of Access to Clinic Entrances (FACE) Act for ... The FACE Act makes it a federal crime to injure, ...
... gut noted in study of people with type 1 version ... abnormal immune response to wheat proteins may contribute to type ... people with type 1 diabetes found that nearly half had ... identified genes associated with this abnormal immune response. , "The ...
... genes that may contribute to drug resistance in non-small ... in the open access journal BMC Cancer ... in drug sensitivity and resistance and actual in vitro ... UK, led a team of researchers who assessed the ...
... ... Association (DIA), in cooperation with FDA and PhRMA, will host Progression-Free Survival Oncology Workshop ... ... Drug Information Association (DIA), in cooperation with FDA and PhRMA, will host ...
... , INDIANAPOLIS, Aug. 26 ... gaming interests reported more than $3.6 million in lobbying expenditures ... Indiana public records. , , Individuals employed ... giving more than $228,000 to state political party committees and ...
Cached Medicine News:Health News:Randall Terry, Abortion, and Health Care: Terry comments on disruption of 'Health Care' Town Hall meeting. 'Yes: We disrupted Howard Dean's speech, and we would do it again. Obama and Pelosi must write into the bill: "No Abortion Funding; No mandates for 2Health News:DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop 2Health News:DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop 3Health News:The Gaming Industry Stacks the Deck Against Smokefree Workplaces in Indiana 2
(Date:3/30/2015)... , March 30, 2015  BioDelivery Sciences ... the primary efficacy endpoint in the Phase 3 ... placebo for the treatment of painful diabetic neuropathy ... endpoints showed statistically significant improvement over placebo.  In ... was observed.  The results of this trial provide ...
(Date:3/29/2015)... TITUSVILLE, N.J. , March 29, 2015 /PRNewswire/ ... delayed time to relapse compared to placebo in ... 3 clinical study published this week in the ... (JAMA) Psychiatry . Results of ... recent New Drug Application (NDA) filing for three-month ...
(Date:3/27/2015)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") ... the issuance of an aggregate of 30,000 stock options ... aggregate of 120,500 stock options to employees and consultants ... three years and will be exercisable for a period ... per stock option. About Covalon Covalon ...
Breaking Medicine Technology:BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 2BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 3BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 4BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Covalon Announces Issuance of Stock Options 2
... Sequella, Inc., a clinical-stage biopharmaceutical company focused on ... announced that it received a $694,000 grant supplement as ... of 2009. The ARRA funds, issued through the National ... National Institute of Health (NIH), will assist Sequella to ...
... Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical ... ) focused on bringing the life saving potential ... nationwide and internationally, said today that it has retired ... of $212,959, $250,000 and $285,000. , On October 2, ...
Cached Medicine Technology:Sequella Receives American Recovery and Reinvestment Funding Through the NIH 2Cord Blood America Continues to Reduce Debt; Three Notes Retired 2
Implex cemented hip stem....
Stability cemented stem....
Porous foundation 440 series....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: